Novel differentiation induction therapy for colorectal cancer by targeting to CEACAM1
Novel differentiation induction therapy for colorectal cancer by targeting to CEACAM1
批准号:
20591554
负责人:
YOKOYAMA Shozo
金额:
$2.41万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2008
资助国家:
日本
项目状态:
已结题
起止时间:
2008 至 2010
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Carcinoembryonic antigen-related cell adhesion molecule 1(CEACAM1) is known to be downregulated at the transcriptional level in adenoma and carcinoma. Recent reports have shown that CEACAM1 is overexpressed at protein level in colorectal cancer, and correlated with clinical stage. The reason why colorectal cancer cells re-expressed CEACAM1 remains unclear. The aim of the present study was to clarify the implication of CEACAM1 re-expression in colorectal cancer. Immunohistochemical analyses were conducted with CEACAM1 long (CEACAM1-L) or short (CEACAM1-S) cytoplasmic domain-specific antibodies on clinical samples from 164 patients with colorectal cancer. The risk factors for metastasis and survival were calculated for clinical implication of CEACAM1 re-expression. Invasion chamber and wound healing assays were performed for the effect of CEACAM1 expression on invasion and migration of colorectal cancer cells. CEACAM1-L and CEACAM1-S stained with greater intensity at the invasion front t … More han at the luminal surface of tumors. Differences between the long and short cytoplasmic isoform expression levels were observed at the invasion front. Multivariate analysis showed that CEACAM1-L dominance was an independent risk factor for lymph node metastasis, hematogenous metastasis, and short survival. The Kaplan-Meier evaluation demonstrated that CEACAM1-L dominance was associated with shorter survival time (p<0.0001). In the invasion chamber and wound healing assays, CEACAM1-L promoted invasion and migration. Re-expression of CEACAM1 is observed at the invasion front of colorectal cancer. CEACAM1-L dominance is associated with metastasis and shorter survival of the patients with colorectal cancer. CEACAM1-L dominance is important for colorectal cancer cells invasion and migration. Tumor budding formed by histological undifferentiated cancer cells beyond the border of tumor margin is associated with lymph node metastasis. However, cancer nests with a hollow, conceivable histological advanced phenotype of tumor budding, has not been discussed. Next we investigate that the appearance "spheroid with a hollow (SWH)" exists beyond the border of the invasive margin, and associates with metastases and prognosis. Moreover, we present that CEACAM1 isoform balance is associated with SWH formation. Immunohistochemical analyses with CEACAM1 and M30 as an apoptosis marker were performed, to address CEACAM1 expression of SWH and central cells apoptosis for SWH formation. The correlations between the SWH beyond the border of the invasive margin and clinicopathological characteristics of 314 patients with colorectal cancer were evaluated. Three dimensional (3D) culture was conducted with colorectal cancer cells transfected with CEACAM1 cDNA or shRNA, to evaluate that CEACAM1 isoform balance controls colorectal SWH formation. The existence of SWH formation accompanying the central cells apoptosis was confirmed by M30 staining and serial section with CEACAM1 staining. Of the 314 patients, 96 (30.4%) were classified as having SWH. SWH is an independent risk factor for metastases and shorter survival. In 3D culture, CEACAM1 isoform balance modulated SWH formation of colorectal cancer cells.The colorectal cancer SWH beyond the border of tumor margin is more important for prediction of malignant potential than tumor budding. Less
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Spheroid with hollow induced by CEACAM1 at the invasion front of colorectal cancer indicates tumor initiating growth and malignant potential.
CEACAM1在结直肠癌侵袭前沿诱导的中空球体表明肿瘤开始生长和恶性潜能。
DOI:
--
发表时间:
2010
期刊:
影响因子:
--
作者:
[Shozo Yokoyama, Koichi Tamura, Junji Ieda, Shigehisa Kiriyama, Katsunari Takifuji, Tsukasa Hotta, Kenji Matsuda, Yoshimasa Oku, Takashi Watanabe, Toru Nasu, Naoyuki Yamamoto, John E. Shively, Hiroki Yamaue]
通讯作者:
Hiroki Yamaue
新たな治療ターゲットである大腸癌発育先進部の分化型細胞巣
结直肠癌发展晚期区域的分化细胞巢是一个新的治疗靶点
DOI:
--
发表时间:
2011
期刊:
影响因子:
--
作者:
[横山省三, 田村耕一, 家田淳司, 瀧藤克也, 堀田司, 松田健司, 奥善全, 那須亨, 橋本忠通, 山本直之, 岩本博光, 山上裕機]
通讯作者:
山上裕機
CEACAM1 expressing spheroid with a hollow beyond the invasive margin indicates the malignant potential of colorectal cancer.
表达 CEACAM1 的球体在浸润边缘之外具有中空,表明结直肠癌的恶性潜力。
DOI:
--
发表时间:
2011
期刊:
影响因子:
--
作者:
[Shozo Yokoyama, Koichi Tamura, Junji Ieda, Shigehisa Kiriyama, Katsunari Takifuji, Tsukasa Hotta, Kenji Matsuda, Yoshimasa Oku, Toru Nasu, Naoyuki Yamamoto, John E. Shively, Hiroki Yamaue]
通讯作者:
Hiroki Yamaue
大腸癌先進部における中空を伴う球体形成の臨床的意義
结直肠癌晚期区域空心球形成的临床意义
DOI:
--
发表时间:
2010
期刊:
影响因子:
--
作者:
[横山省三, 田村耕一, 家田淳司, 瀧藤克也, 堀田司, 松田健司, 奥喜全, 渡邉高士, 那須亨, 桐山茂久, 山本直之, John E. Shively, 山上裕機]
通讯作者:
山上裕機
CEACAM1 and CD133 expressing Spheroid with hollow at the invasion front of colorectal cancer-Novel metastatic and tumor inifiating phenotype-.
结直肠癌侵袭前沿具有中空表达 CEACAM1 和 CD133 的球体-新型转移和肿瘤起始表型-。
DOI:
--
发表时间:
2010
期刊:
影响因子:
--
作者:
[喜島祐子, 他, Shozo Yokoyama]
通讯作者:
Shozo Yokoyama
共 13 条
Novel therapeutic starategy for CEACAM1 expressing colorectal cancer cells beyond the invasion front
-
批准号:23591904
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.66万
-
财政年份:2011
-
负责人:YOKOYAMA Shozo
-
依托单位:
Error Analysis of medical research articles by Japanese learner and its application to instruction based on learner corpus data
-
批准号:22590477
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.83万
-
财政年份:2010
-
负责人:YOKOYAMA Shozo
-
依托单位:
Developing a Corpus-based E-learning System for Teaching Reading and Writing Medical/Nursing English
-
批准号:17320087
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$4.75万
-
财政年份:2005
-
负责人:YOKOYAMA Shozo
-
依托单位:
Research on Effective Syllabus Design and Materials Development for Teaching ESP at the Tertiary Level
-
批准号:15520362
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.05万
-
财政年份:2003
-
负责人:YOKOYAMA Shozo
-
依托单位:
Process of formation of large-ignimbrite plateaus
-
批准号:02680202
-
项目类别:Grant-in-Aid for General Scientific Research (C)
-
资助金额:$1.41万
-
财政年份:1990
-
负责人:YOKOYAMA Shozo
-
依托单位:
Process of dissection of initial form of large-scale pyroclastic flow deposits
-
批准号:60580202
-
项目类别:Grant-in-Aid for General Scientific Research (C)
-
资助金额:$1.22万
-
财政年份:1985
-
负责人:YOKOYAMA Shozo
-
依托单位:
国内基金
海外基金
登录
查看更多内容
升降散调控 CEACAM1/NLRP3/焦亡轴减轻脓毒症肝损伤
-
批准号:2024JJ8203
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:刘艳娟
-
依托单位:
可溶性TIM-3通过CEACAM1调控NK细胞功能参与肝癌进展的机制研究
-
批准号:2023JJ50293
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:许勇
-
依托单位:
STAT3/hsa-miR-487a/CEACAM1反馈调控环路促进乳腺癌转移的作用和机制研究
-
批准号:82260582
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:杨长成
-
依托单位:
CEACAM1通过调控细胞粘附介导PTPRZ1-MET融合阳性复发胶质瘤患者靶向治疗抵抗的机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:曾凡
-
依托单位:
miR-31 靶向CEACAM1调控系统性红斑狼疮Treg细胞稳态的机制研究
-
批准号:2021JJ40292
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2021
-
负责人:刘艳娟
-
依托单位:
HIF-1α/CEACAM1/VEGFR-2 信号通路在糖尿病视网膜内皮细胞缺氧损伤中的作用机制研究
-
批准号:LY22H120004
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2021
-
负责人:张丽
-
依托单位:
CEACAM1通过CD73/嘌呤能信号改善糖尿病冠脉微血管功能障碍的作用及机制研究
-
批准号:82160076
-
项目类别:地区科学基金项目
-
资助金额:34万元
-
批准年份:2021
-
负责人:汪艳
-
依托单位:
免疫细胞表面分子TIM-3/CEACAM1共表达对结直肠癌的诊断及预后研究
-
批准号:81902135
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2019
-
负责人:张杨
-
依托单位:
CEACAM1通过Notch1信号通路调节心房细胞代谢重构在房颤中的作用
-
批准号:81960069
-
项目类别:地区科学基金项目
-
资助金额:34.0万元
-
批准年份:2019
-
负责人:王静
-
依托单位:
雷帕霉素与他克莫司调控CD4+T细胞亚群GAL-9/CEACAM1/TIM-3/BAT3信号通路在参与肾移植受者慢性移植物失功中的机制研究
-
批准号:81771714
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2017
-
负责人:石运莹
-
依托单位: